SBCM
CLB icon

Silver Bridge Capital Management’s Core Laboratories CLB Stock Holding History

Silver Bridge Capital Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-2,665
Closed -$404K – 37
2013
Q2 		$404K Buy
+2,665
New +$378K 0.07% 159

Other funds holding CLB

CG
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Silver Bridge Capital Management's CLB Position: Q3 2013 in Review

Silver Bridge Capital Management sold out of Core Laboratories (CLB) in Q3 2013, closing a stake of 2,665 shares — an estimated $404K sold.

Silver Bridge Capital Management first reported a position in CLB in Q2 2013 and held it in 1 quarter. The position peaked at $404K in Q2 2013. 302 funds tracked by Wall St. Rank hold CLB as of Q3 2013.

  • Silver Bridge Capital Management reported no remaining Core Laboratories position as of Q3 2013 after selling out during the quarter.
  • Silver Bridge Capital Management sold 2,665 Core Laboratories shares in Q3 2013, an estimated $404K.
  • Silver Bridge Capital Management first reported a position in Core Laboratories in Q2 2013 and held it in 1 quarter.
  • Silver Bridge Capital Management's Core Laboratories position peaked at $404K in Q2 2013.
  • 302 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2013.

Based on Silver Bridge Capital Management's 13F filing for Q3 2013.